March 28, 2026 15:00 ET | Source: Roivant Sciences The results of the Phase 3 VALOR trial were published in…
“Persistent kidney inflammation is a hallmark of IgAN, and a key driver of disease progression, leading to ongoing kidney damage…
Largo, FL, March 28, 2026 (GLOBE NEWSWIRE) -- This release reflects growing consumer discussions and publicly available information surrounding the…
Aurora, CO, March 28, 2026 (GLOBE NEWSWIRE) -- The following report is for informational purposes only. It is not medical…
Johnson & Johnson presents findings from the largest European real-world dataset for esketamine nasal spray (NS) which confirm its effectiveness…
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World…
Nashville, TN, March 27, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…
March 27, 2026 10:40 ET | Source: Artelo Biosciences SOLANA BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences,…
March 27, 2026 10:30 ET | Source: Celldex Therapeutics, Inc. - Improvements seen across all six DLQI Domains indicating broad,…
Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin…